203 related articles for article (PubMed ID: 18350547)
1. Glycolipid-activated NKT cells support the induction of persistent plasma cell responses and antibody titers.
Devera TS; Shah HB; Lang GA; Lang ML
Eur J Immunol; 2008 Apr; 38(4):1001-11. PubMed ID: 18350547
[TBL] [Abstract][Full Text] [Related]
2. Requirement for CD1d expression by B cells to stimulate NKT cell-enhanced antibody production.
Lang GA; Devera TS; Lang ML
Blood; 2008 Feb; 111(4):2158-62. PubMed ID: 18077787
[TBL] [Abstract][Full Text] [Related]
3. The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner.
Lang GA; Exley MA; Lang ML
Immunology; 2006 Sep; 119(1):116-25. PubMed ID: 16792697
[TBL] [Abstract][Full Text] [Related]
4. Glycolipids as immune modulatory tools.
Lalazar G; Preston S; Zigmond E; Ben Yáacov A; Ilan Y
Mini Rev Med Chem; 2006 Nov; 6(11):1249-53. PubMed ID: 17100636
[TBL] [Abstract][Full Text] [Related]
5. Critical role for the chemokine receptor CXCR6 in homeostasis and activation of CD1d-restricted NKT cells.
Germanov E; Veinotte L; Cullen R; Chamberlain E; Butcher EC; Johnston B
J Immunol; 2008 Jul; 181(1):81-91. PubMed ID: 18566372
[TBL] [Abstract][Full Text] [Related]
6. Regulation of immune responses by CD1d-restricted natural killer T cells.
Van Kaer L
Immunol Res; 2004; 30(2):139-53. PubMed ID: 15477656
[TBL] [Abstract][Full Text] [Related]
7. Regulation of anthrax toxin-specific antibody titers by natural killer T cell-derived IL-4 and IFNγ.
Devera TS; Joshi SK; Aye LM; Lang GA; Ballard JD; Lang ML
PLoS One; 2011; 6(8):e23817. PubMed ID: 21858226
[TBL] [Abstract][Full Text] [Related]
8. BAFF- and APRIL-dependent maintenance of antibody titers after immunization with T-dependent antigen and CD1d-binding ligand.
Shah HB; Joshi SK; Rampuria P; Devera TS; Lang GA; Stohl W; Lang ML
J Immunol; 2013 Aug; 191(3):1154-63. PubMed ID: 23797666
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cell differentiation state and their interaction with NKT cells determine Th1/Th2 differentiation in the murine model of Leishmania major infection.
Wiethe C; Debus A; Mohrs M; Steinkasserer A; Lutz M; Gessner A
J Immunol; 2008 Apr; 180(7):4371-81. PubMed ID: 18354157
[TBL] [Abstract][Full Text] [Related]
10. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
[TBL] [Abstract][Full Text] [Related]
11. Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides.
Ortaldo JR; Young HA; Winkler-Pickett RT; Bere EW; Murphy WJ; Wiltrout RH
J Immunol; 2004 Jan; 172(2):943-53. PubMed ID: 14707067
[TBL] [Abstract][Full Text] [Related]
12. CD1d-dependent expansion of NKT follicular helper cells in vivo and in vitro is a product of cellular proliferation and differentiation.
Rampuria P; Lang ML
Int Immunol; 2015 May; 27(5):253-63. PubMed ID: 25710490
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of host NKT cells by synthetic glycolipid regulates acute graft-versus-host disease by inducing Th2 polarization of donor T cells.
Hashimoto D; Asakura S; Miyake S; Yamamura T; Van Kaer L; Liu C; Tanimoto M; Teshima T
J Immunol; 2005 Jan; 174(1):551-6. PubMed ID: 15611282
[TBL] [Abstract][Full Text] [Related]
14. CD40L-null NKT cells provide B cell help for specific antibody responses.
Shah HB; Joshi SK; Lang ML
Vaccine; 2011 Nov; 29(49):9132-6. PubMed ID: 21959330
[TBL] [Abstract][Full Text] [Related]
15. Activation of invariant NKT cells by the helminth parasite schistosoma mansoni.
Mallevaey T; Zanetta JP; Faveeuw C; Fontaine J; Maes E; Platt F; Capron M; de-Moraes ML; Trottein F
J Immunol; 2006 Feb; 176(4):2476-85. PubMed ID: 16456008
[TBL] [Abstract][Full Text] [Related]
16. Reduction of CD1d expression in vivo minimally affects NKT-enhanced antibody production but boosts B-cell memory.
Lang GA; Johnson AM; Devera TS; Joshi SK; Lang ML
Int Immunol; 2011 Apr; 23(4):251-60. PubMed ID: 21398691
[TBL] [Abstract][Full Text] [Related]
17. CD1d-restricted NKT cells contribute to malarial splenomegaly and enhance parasite-specific antibody responses.
Hansen DS; Siomos MA; De Koning-Ward T; Buckingham L; Crabb BS; Schofield L
Eur J Immunol; 2003 Sep; 33(9):2588-98. PubMed ID: 12938235
[TBL] [Abstract][Full Text] [Related]
18. α-Galactosylceramide-Reactive NKT Cells Increase IgG1 Class Switch against a Clostridioides difficile Polysaccharide Antigen and Enhance Immunity against a Live Pathogen Challenge.
Lang GA; Shrestha B; Amadou Amani S; Shadid TM; Ballard JD; Lang ML
Infect Immun; 2021 Oct; 89(11):e0043821. PubMed ID: 34424751
[TBL] [Abstract][Full Text] [Related]
19. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.
Nishimura T; Kitamura H; Iwakabe K; Yahata T; Ohta A; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nakui M; Sekimoto M; Koda T
Int Immunol; 2000 Jul; 12(7):987-94. PubMed ID: 10882410
[TBL] [Abstract][Full Text] [Related]
20. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
